• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) ORBERA INTRAGASTRIC BALLOON; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) ORBERA INTRAGASTRIC BALLOON; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Catalog Number B-50000
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Abdominal Pain (1685)
Event Date 07/04/2015
Event Type  Injury  
Manufacturer Narrative
The reporter of the complaint was asked to return the product for analysis.The device has not yet been received by allergan.Allergan has not received the product at this time.Therefore no analysis or testing has been done.Pain is a surgical/physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.No additional information has been reported to allergan regarding patient data or further event details.Device labeling addresses the reported event of pain as follows: possible complications of the use of the orbera system include: abdominal or back pain, either steady or cyclic.
 
Event Description
Healthcare professional reported abdominal x-ray "showed air hyperinsuflation in the balloon and patient with intense abdominal pain".The device was explanted without replacement.
 
Manufacturer Narrative
(b)(4).
 
Event Description
Healthcare professional reported abdominal x-ray "showed air hyperinsuflation in the balloon and patient with intense abdominal pain." the device was explanted without replacement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON
Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS  
Manufacturer Contact
laura leboeuf
1120 s capital of texas hwy
bulding 1, suite 300
austin, TX 78748
8555513123
MDR Report Key5077914
MDR Text Key25821046
Report Number3006722112-2015-00368
Device Sequence Number1
Product Code LTI
UDI-Device Identifier10811955020541
UDI-Public(01)10811955020541(10)2690095(11)150107(17)170107
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 08/26/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/07/2017
Device Catalogue NumberB-50000
Device Lot Number2690095
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/26/2015
Initial Date FDA Received09/15/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/07/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age53 YR
-
-